NCT Number: NCT00466063
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
This registry will evaluate long-term safety and efficacy of deferasirox in children with transfusional iron overload.
Looking for future studies?
Notify MeKey information
Conditions
Age range
2 year–5 year
Sex eligibility
All sexes
Study type
Observational
Primary location
University of South Alabama Medical Center, Mobile, Alabama, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- History of transfusion-dependent anemia.
- History of iron overload
Exclusion criteria
- Patients with non-transfusional hemosiderosis.
Other protocol-defined inclusion/exclusion criteria may apply.
Treatment and study plan
Primary outcomes
-
Safety - renal and hepatic function monitoring.
Time frame: 5 years
Secondary outcomes
-
Adverse events
Time frame: 5 years
-
Longitudinal ferritin levels
Time frame: 5 years
-
Assessment of auditory and ophthalmologic status
Time frame: 5 years
Sponsors and collaborators
Lead sponsor
Novartis Pharmaceuticals
Industry
Registry information
Official study title
A 5 Year Observational Study (Registry) of Children Aged 2 to <6 Years at Enrollment With Transfusional Hemosiderosis Treated With Deferasirox
Important dates
- Study start
- 2007
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Apr 27, 2007
- Registry last updated
- Dec 29, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
NCT00303329
Anemia, Hematologic Diseases
Oakland, California, United States
View Trial DetailsPerennial Malaria Chemoprevention (PMC) in Cameroon
NCT05889052
Anemia, Hematologic Diseases
Soa and Mbankomo, Cameroon
View Trial DetailsPerennial Malaria Chemoprevention (PMC) in Côte d'Ivoire
NCT05856357
Anemia, Hematologic Diseases
Séguéla, Côte d’Ivoire
View Trial DetailsCan Pre-operative Anemia be Timely Identified and Optimized in Patients Awaiting Primary Arthroplasty Surgery? A Randomized Clinical Trial
NCT05648942
Anemia, Arthritis
Ottawa, Ontario, Canada
View Trial Details